147 related articles for article (PubMed ID: 12401153)
1. Management of the low-grade abnormal Pap smear: What are women's preferences?
Melnikow J; Kuppermann M; Birch S; Chan BK; Nuovo J
J Fam Pract; 2002 Oct; 51(10):849-55. PubMed ID: 12401153
[TBL] [Abstract][Full Text] [Related]
2. HPV triage testing or repeat Pap smear for the management of atypical squamous cells (ASCUS) on Pap smear: is there evidence of process utility?
Howard K; Salkeld G; McCaffery K; Irwig L
Health Econ; 2008 May; 17(5):593-605. PubMed ID: 17764095
[TBL] [Abstract][Full Text] [Related]
3. Human papillomavirus (HPV) testing in the management of women with abnormal Pap smears. Experience of a colposcopy referral clinic.
Ciotti M; Sesti F; Paba P; Benedetto A; Patrizi L; Criscuolo A; Piccione E; Branca M; Syrjänen K; Favalli C
Eur J Gynaecol Oncol; 2004; 25(5):577-84. PubMed ID: 15493169
[TBL] [Abstract][Full Text] [Related]
4. Women's triage and management preferences for cervical cytologic reports demonstrating atypical squamous cells of undetermined significance and low-grade squamous intraepithelial lesions.
Ferris DG; Kriegel D; Cote L; Litaker M; Woodward L
Arch Fam Med; 1997; 6(4):348-53. PubMed ID: 9225706
[TBL] [Abstract][Full Text] [Related]
5. Clinical value of repeat Pap smear at the time of colposcopy.
Zardawi IM; Rode JW
Acta Cytol; 2002; 46(3):495-8. PubMed ID: 12040643
[TBL] [Abstract][Full Text] [Related]
6. Identifying women with cervical neoplasia: using human papillomavirus DNA testing for equivocal Papanicolaou results.
Manos MM; Kinney WK; Hurley LB; Sherman ME; Shieh-Ngai J; Kurman RJ; Ransley JE; Fetterman BJ; Hartinger JS; McIntosh KM; Pawlick GF; Hiatt RA
JAMA; 1999 May; 281(17):1605-10. PubMed ID: 10235153
[TBL] [Abstract][Full Text] [Related]
7. A comparison of the reliability of repeat cervical smears and colposcopy in patients with abnormal cervical cytology.
Mayeaux EJ; Harper MB; Abreo F; Pope JB; Phillips GS
J Fam Pract; 1995 Jan; 40(1):57-62. PubMed ID: 7807039
[TBL] [Abstract][Full Text] [Related]
8. Managing atypical squamous cells of undetermined significance in Papanicolaou smears.
Morin C; Bairati I; Bouchard C; Fortier M; Roy M; Moore L; Meisels A
J Reprod Med; 2001 Sep; 46(9):799-805. PubMed ID: 11584480
[TBL] [Abstract][Full Text] [Related]
9. Management of patients with atypical and low-grade Pap smear abnormalities.
Nuovo J; Melnikow J; Paliescheskey M
Am Fam Physician; 1995 Dec; 52(8):2243-50. PubMed ID: 7484718
[TBL] [Abstract][Full Text] [Related]
10. Triage of women with ASCUS and LSIL on Pap smear reports: management by repeat Pap smear, HPV DNA testing, or colposcopy?
Ferris DG; Wright TC; Litaker MS; Richart RM; Lorincz AT; Sun XW; Borgatta L; Buck H; Kramer L; Rubin R
J Fam Pract; 1998 Feb; 46(2):125-34. PubMed ID: 9487318
[TBL] [Abstract][Full Text] [Related]
11. Should all women with cervical atypia be referred for colposcopy: a HARNET study. Harrisburgh Area Research Network.
Slawson DC; Bennett JH; Simon LJ; Herman JM
J Fam Pract; 1994 Apr; 38(4):387-92. PubMed ID: 8163964
[TBL] [Abstract][Full Text] [Related]
12. Do follow-up recommendations for abnormal Papanicolaou smears influence patient adherence?
Melnikow J; Chan BK; Stewart GK
Arch Fam Med; 1999; 8(6):510-4. PubMed ID: 10575390
[TBL] [Abstract][Full Text] [Related]
13. The adequacy of management of women with CIN 2 and CIN 3 Pap smear abnormalities.
Towler BP; Irwig LM; Shelley JM
Med J Aust; 1993 Oct; 159(8):523, 526-8. PubMed ID: 8412951
[TBL] [Abstract][Full Text] [Related]
14. Performance of the Roche AMPLICOR human papillomavirus (HPV) test in prediction of cervical intraepithelial neoplasia (CIN) in women with abnormal PAP smear.
Monsonego J; Bohbot JM; Pollini G; Krawec C; Vincent C; Merignargues I; Haroun F; Sednaoui P; Monfort L; Dachez R; Syrjänen K
Gynecol Oncol; 2005 Oct; 99(1):160-8. PubMed ID: 16023184
[TBL] [Abstract][Full Text] [Related]
15. Management choices for patients with "squamous atypia" on Papanicolaou smear. A toss up?
Melnikow J; Nuovo J; Paliescheskey M
Med Care; 1996 Apr; 34(4):336-47. PubMed ID: 8606558
[TBL] [Abstract][Full Text] [Related]
16. Preferences for surveillance strategies for women treated for high-grade precancerous cervical lesions.
Kuppermann M; Melnikow J; Slee C; Tancredi DJ; Kulasingam S; Birch S; Helms LJ; Bayoumi AM; Sawaya GF
Gynecol Oncol; 2010 Aug; 118(2):108-15. PubMed ID: 20553960
[TBL] [Abstract][Full Text] [Related]
17. Normal colposcopy following abnormal Pap smear evoking LGSIL: a follow-up study.
Kourounis G; Ravazoula P; Michail G
Eur J Gynaecol Oncol; 2004; 25(5):623-4. PubMed ID: 15493181
[TBL] [Abstract][Full Text] [Related]
18. Should the Pap smear be repeated at the first colposcopy visit?
Dolman G; Tan J; Quinn M
Aust N Z J Obstet Gynaecol; 2005 Dec; 45(6):514-7. PubMed ID: 16401219
[TBL] [Abstract][Full Text] [Related]
19. Microcolposcopy vs colposcopy in evaluating abnormal Pap smear. Comparison with histological findings.
Framarino dei Malatesta ML; Carraro C; Silvestrini I; Marzetti L; Vecchione A
Clin Exp Obstet Gynecol; 1993; 20(4):236-40. PubMed ID: 8281705
[TBL] [Abstract][Full Text] [Related]
20. Colposcopy in women with a normal Papanicolaou smear.
Peedicayil A; Regi A; Mathai M; Jasper P
Natl Med J India; 1994; 7(5):208-9. PubMed ID: 7827598
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
